Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
Concert Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
Concert Pharmaceuticals reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at Concert Pharmaceuticals received on average a compensation package of $3M, a 22% increase compared to previous year.
Average pay of disclosed executives at Concert Pharmaceuticals
- Salary
- Stock
- Options
- Non-Equity Incentive
- Bonus
- Other
Roger D. Tung, Chief Executive Officer, received $4.6M in total, which increased by 34% compared to 2017. 82% of Tung's compensation, or $3.8M, was in option awards. Tung also received $300K in non-equity incentive plan, $536K in salary, as well as $10K in other compensation.
Marc Becker, Chief Financial Officer, received a compensation package of $2.5M. 77% of the compensation package, or $1.9M, was in option awards.
Nancy Stuart, Chief Operating Officer, earned $1.9M in 2018, a 2% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2019.